Brief: Poseida Therapeutics Announces FDA Clearance Of Investigational New Drug Application For P-MUC1C-ALLO1

Poseida Therapeutics

20/12/2021 13:21

Dec 20 (Reuters) - Poseida Therapeutics Inc  PSTX.O :
    * POSEIDA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF
INVESTIGATIONAL
NEW DRUG APPLICATION FOR P-MUC1C-ALLO1, A FULLY ALLOGENEIC CAR-T
TARGETING MULTIPLE SOLID TUMORS

Source text for Eikon:  ID:nPn7cZvfla 
Further company coverage:  PSTX.O